Press Release
RSS/Syndication
SearchLupin acquires minority stake in Australian drug firm
Indian drug major Lupin Ltd has acquired a minority stake in Generic Health Pty Ltd, an Australian pharmaceutical company, it announced Thursday.
- BharatMatrimony launches World's first matrimony channel on the Internet
- Roby Abraham is new CEO of Excel Home Videos
- iYogi Partners with GlobalLogic for Software Product Development to Create "Generation V" Technical Support Platform
- AMD Delivers Groundbreaking Platform for Ultrathin Notebooks
- BIGFlix.com joins hands with the Kishore Biyani's Future Group
Indian drug major Lupin Ltd has acquired a minority stake in Generic Health Pty Ltd, an Australian pharmaceutical company, it announced Thursday.
'Lupin has established its presence in this market through partnership business model. It has filed 16 dossiers of generic products with a total market size of about A$850 million ($740.52 million) and has approvals for 14 of these,' the company said in a regulatory statement.
The Australian pharmaceutical market is valued at over A$10 billion ($8.71 billion), with the generics business including branded generics accounting for A$3 billion ($2.61 billion).
'We have built a significant business in this market, leveraging our existing alliances with local generic companies,' said Vinod Dhawan, president of the company's operations in Asia, Africa, Middle East and Latin America, in a statement.
Copyright © India PRwire/Indo Asian News Service. Reproduction of news articles or any other content in whole or in part in any form or medium without express written permission of India PRwire is prohibited.